About
Glyphic Bio — Next Generation Protein Sequencing Company.
We sequence proteins. Glyphic Biotechnologies is decoding the human proteome through full coverage, de novo protein sequencing at single molecule resolution to enable the development of novel therapeutics and diagnostics and, ultimately, a deeper understanding of life itself.
Value proposition
Glyphic Biotechnologies is building ProSE, a single-molecule method for sequencing proteins at full coverage. For researchers developing therapeutics and diagnostics who cannot read the whole proteome with today's tools.
- Business
- Health and bio company
